Don Dempsey reportedly in frame to serve as Office of Management and Budget’s leading health offical, a role that would hand him sweeping powers to rein in Kennedy’s ambitions ...
HHS Secretary nominee Robert F. Kennedy Jr. will divest his interests in several biopharma companies, including CRISPR ...
Thermo Fisher Scientific should be safe. RFK Jr. may disrupt Big Pharma, but he’s unlikely to cause research to completely ...
8hon MSN
President Donald Trump is remaking the traditional boundaries of Washington, asserting unprecedented executive power and ...
Trump returns to the White House as the tenth wave of the COVID-19 pandemic once again inundates hospitals, while the last ...
Trump 2.0 prioritizes AI and space, while infectious disease and climate research decline in South Koreas context Trump 2.0s ...
Robert Lighthizer, the former U.S. Trade Representative, lost his bid to rejoin the White House, but he still believes the ...
Following his win over Kamala Harris, Donald Trump has been assembling the administration for his second term in the White ...
George Washington is the only president of the United States whose inauguration took place in New York City, then the ...
Jon Hochschartner Anyone who cares about animals should oppose Robert F. Kennedy Jr., President-Elect Donald Trump’s nominee for secretary of Health and Human Services. Available evidence suggests he ...
In his inaugural address, President Donald Trump promised to reform the public health system and reverse actions taken ...
At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback